Galectin Therapeutics Inc.
GALT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,184 | -$7,521 | -$9,631 | -$11,967 |
| Dep. & Amort. | $0 | $2 | $10 | $10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $496 | $500 | $468 | $0 |
| Change in WC | $1,726 | -$1,028 | $1,092 | $326 |
| Other Non-Cash | $2,420 | $1,445 | $372 | -$1,160 |
| Operating Cash Flow | -$3,542 | -$6,602 | -$7,689 | -$12,791 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $11,000 | $0 | $0 |
| Stock Issued | $853 | $1,942 | $0 | $851 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $443 | $0 | $0 | $0 |
| Financing Cash Flow | $1,296 | $12,942 | $0 | $851 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,246 | $6,340 | -$7,689 | -$11,940 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,771 | $7,431 | $15,120 | $27,060 |
| End Cash | $11,525 | $13,771 | $7,431 | $15,120 |
| Free Cash Flow | -$3,542 | -$6,602 | -$7,689 | -$12,791 |